AI assistant
Sending…
Sunshine Biopharma Inc. — Director's Dealing 2021
Feb 16, 2021
35352_dirs_2021-02-16_793b9783-0cbe-4ac1-afaa-16b214af619a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sunshine Biopharma, Inc (SBFM)
CIK: 0001402328
Period of Report: 2021-01-06
Reporting Person: Sebaaly Camille (Director, CFO/Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-06 | Common Stock | A | 20000000 | $0.001 | Acquired | 23893086 | Direct |
More from Sunshine Biopharma Inc.
Share Issue/Capital Change
2026
May 29
Capital/Financing Update
2026
May 19
Share Issue/Capital Change
2026
May 19
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Apr 9
Annual Report
2026
Apr 3
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 20
Board/Management Information
2026
Feb 5
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 12
Interim / Quarterly Report
2025
Nov 13